Skip to the content
VYNE Therapeutics
Rooted in Innovation
About Us
About VYNE™
Our Mission
Who We Are
Leadership
Board of Directors
Scientific Advisory Board
Corporate Responsibility
Pipeline
Pipeline Overview
InhiBET™ BET Inhibitor Platform
VYN201
VYN202
FMX114 Program
Careers
Investors & Media
Investor Overview
Stock Information
Press Releases
Events & Presentations
ES&G / Culture
Corporate Governance
Filings & Financials
Contact Us
Search
Menu
Search for:
Search
Close search
Close
About Us
About VYNE™
Our Mission
Who We Are
Leadership
Board of Directors
Scientific Advisory Board
Corporate Responsibility
Pipeline
Pipeline Overview
InhiBET™ BET Inhibitor Platform
VYN201
VYN202
FMX114 Program
Careers
Investors & Media
Investor Overview
Stock Information
Press Releases
Events & Presentations
ES&G / Culture
Corporate Governance
Filings & Financials
Contact Us
Pipeline Overview
Developing innovative therapies for
immuno–inflammatory
conditions
VYNE Therapeutics
VYNE Therapeutics